Chronic Lung Diseases Completed Phase 4 Trials for Omalizumab (DB00043)

Also known as: Lung Disease / Lung Diseases / Chronic Lung Disease / Calcification of lung / Disorder lung / Lung disorder / Lung disorder (NOS) / Lung disorder NOS / Pulmonary disorder / Disorder pulmonary / Pneumopathy

IndicationStatusPhase
DBCOND0044039 (Chronic Lung Diseases)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00139152Non-invasive Ways to Evaluate Lung Disease After Treatment With XolairTreatment